Observational studyBritish journal of haematology2025

Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study.

Federico Stella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.